Rituximab (MabThera)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Rituximab (MabThera), covering 2015-12-10 to 2018-10-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) [Phase 3]